This inventor holds 8 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignees: Agency for Science, Technology and Research, Euchloe Bio Pte. Ltd., Singapore Health Services Pte Ltd. Active years: 2019-2026.
Company Filing History:
8 out of 1,557 
1 out of 1 
1 out of 140 
Years Active: 2019-2026
Title: Innovations of John Edward Connolly
Introduction
John Edward Connolly is a prominent inventor based in Singapore, known for his significant contributions to the field of biotechnology. He holds a total of seven patents, showcasing his expertise and innovative spirit in developing advanced therapeutic solutions.
Latest Patents
Among his latest patents are the IL2Rbeta/common gamma chain antibodies, which are antigen binding molecules capable of binding to CD122 and/or common gamma chain (CD132). These patents also disclose compositions comprising such antigen binding molecules, along with various uses and methods utilizing them. Another notable patent is for IL2R common gamma chain antibodies, which includes anti-CD122 and/or γc antibodies and fragments thereof. This patent also details compositions that include these antibodies and fragments, as well as their applications and methods.
Career Highlights
John Edward Connolly has worked with esteemed organizations such as the Agency for Science, Technology and Research and Tessa Therapeutics Pte. Ltd. His work in these institutions has allowed him to push the boundaries of scientific research and innovation.
Collaborations
Throughout his career, Connolly has collaborated with notable colleagues, including Peter Brauer and Siok Ping Yeo. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
John Edward Connolly's innovative work in biotechnology, particularly in the development of antibodies, has made a significant impact in the field. His patents reflect his dedication to advancing medical science and improving therapeutic options for patients.